[{"NetIncomeLoss_2_Q2_USD":-106769000.0,"OperatingLeaseLiability_0_Q2_USD":18842000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":20241000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":9819000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":90581000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":90753000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":9643000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":953000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":103000000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":96223000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":22.57,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":249000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":868000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":4178000.0,"OperatingLeaseExpense_2_Q2_USD":2000000.0,"OperatingLeaseExpense_1_Q2_USD":1000000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":66915000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":19627000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":9005000.0,"SellingAndMarketingExpense_2_Q2_USD":35785000.0,"SellingAndMarketingExpense_1_Q2_USD":15589000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":805000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":4058000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":166825000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":12820000.0,"AssetsCurrent_0_Q2_USD":392895000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":220114000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":245000.0,"Liabilities_0_Q2_USD":108663000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":44004000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":20.46,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":22753000.0,"ValuationAllowancesAndReservesDeductions_2_Q2_USD":67526000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1714000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":559000.0,"AccountsReceivableNetCurrent_0_Q2_USD":37502000.0,"CommonStockValue_0_Q2_USD":908000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":1366000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":484000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-4055000.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":-11756000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":2819000.0,"CostsAndExpenses_1_Q2_USD":78417000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":300800000.0,"IncreaseDecreaseInInventories_2_Q2_USD":16474000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q2_USD":0.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-105901000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-54945000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":15700000.0,"OtherAssetsNoncurrent_0_Q2_USD":346000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":80728000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":16012000.0,"CostsAndExpenses_2_Q2_USD":156551000.0,"Assets_0_Q2_USD":432721000.0,"ShareBasedCompensation_2_Q2_USD":23088000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":17594000.0,"AssetImpairmentCharges_2_Q2_USD":53000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":953000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":11114000.0,"ValuationAllowancesAndReservesBalance_0_Q2_USD":19110000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-90212000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":18979000.0,"ProceedsFromWarrantExercises_2_Q2_USD":3000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":3942000.0,"LiabilitiesCurrent_0_Q2_USD":92651000.0,"AccountsPayableCurrent_0_Q2_USD":18458000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":80728000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-2377000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":1507000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1309000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":23728000.0,"AdditionalPaidInCapital_0_Q2_USD":1594436000.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":7600000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":124000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":1507000.0,"OperatingLeasePayments_2_Q2_USD":1700000.0,"OperatingLeasePayments_1_Q2_USD":1000000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":21886000.0,"AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_1_Q2_USD":109000.0,"NetIncomeLoss_1_Q2_USD":-55190000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":13109000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":8830000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1272239000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":16306000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":3911000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":4274000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-10136000.0,"OperatingIncomeLoss_2_Q2_USD":-108483000.0,"OperatingIncomeLoss_1_Q2_USD":-55749000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_2_Q2_USD":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":220114000.0,"InventoryNet_0_Q2_USD":41442000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":19.24,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":10.57,"LiabilitiesAndStockholdersEquity_0_Q2_USD":432721000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":11193000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":23088000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":11114000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":645000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2830000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.18,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.61,"StockholdersEquity_0_Q2_USD":324058000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":3687000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":219161000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":82000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":48068000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":22668000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":80898000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1922000.0,"Ticker":"HRTX","CIK":"818033","name":"HERON THERAPEUTICS, INC. \/DE\/","OfficialName":"Heron Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"558709361.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]